Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Merck
Colorcon
AstraZeneca
Mallinckrodt

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Chloramphenicol sodium succinate - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for chloramphenicol sodium succinate and what is the scope of patent protection?

Chloramphenicol sodium succinate is the generic ingredient in four branded drugs marketed by Elkins Sinn, Fresenius Kabi Usa, Gruppo Lepetit, Parkedale, and Angus, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for chloramphenicol sodium succinate. One supplier is listed for this compound.

Summary for chloramphenicol sodium succinate
Pharmacology for chloramphenicol sodium succinate
Synonyms for chloramphenicol sodium succinate
3544-94-3 (Parent)
872109HX6B
982-57-0
AC1LCVLH
Acetamide, 2,2-dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)-, alpha-ester with sodium succinate
Acetamide, 2,2-dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)-,alpha-ester with sodium succinate
AKOS016340429
API0001951
Butanedioic acid, mono((2R,3R)-2-((dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl) ester, monosodium salt
Butanedioic acid, mono(2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl) ester, monosodium salt, (R-(R(sup *),R(sup *)))(-)
Butanedioic acid, mono(2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl) ester, monosodium salt, (R-(R*,R*))-
C-22411
C13962
C15H15Cl2N2O8.Na
CAS-982-57-0
CCG-212521
CCRIS 6204
CHEMBL1200729
Chloramphenicol succinate sodium
Chloramphenicol alpha-succinate
Chloramphenicol monosuccinate sodium salt
Chloramphenicol sodium monosuccinate
Chloramphenicol sodium succinate (JP17/USP)
Chloramphenicol sodium succinate [USAN]
Chloramphenicol sodium succinate [USP:BAN:JAN]
Chloramphenicol sodium succinate, d-
Chloramphenicol succinate sodium
Chloramphenicol succinate sodium salt
Chloramphenicol-sukzinat-natrium
Chloramphenicol-sukzinat-natrium [German]
Chloromycetin succinate (TN)
d-Chloramphenicol sodium succinate
D-threo-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide alpha-(sodium succinate)
D02185
DSSTox_CID_4747
DSSTox_GSID_24747
DSSTox_RID_77520
DTXSID2024747
EINECS 213-568-1
KS-5158
LS-2196
MFCD00079025
MolPort-006-112-736
Mychel-s
NCGC00094619-04
NCGC00094619-06
Protophenicol
SCHEMBL193134
sodium 4-((2R,3R)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propoxy)-4-oxobutanoate
sodium 4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoate
Sodium chloramphenicol succinate
Tox21_113484
Tox21_113484_1
UNII-872109HX6B
V1707
W-100087

US Patents and Regulatory Information for chloramphenicol sodium succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elkins Sinn CHLORAMPHENICOL chloramphenicol sodium succinate INJECTABLE;INJECTION 062406-001 Nov 9, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parkedale CHLOROMYCETIN chloramphenicol sodium succinate INJECTABLE;INJECTION 050155-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Gruppo Lepetit CHLORAMPHENICOL SODIUM SUCCINATE chloramphenicol sodium succinate INJECTABLE;INJECTION 062278-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa CHLORAMPHENICOL SODIUM SUCCINATE chloramphenicol sodium succinate INJECTABLE;INJECTION 062365-001 Aug 25, 1982 RX No Yes   Start Trial   Start Trial   Start Trial
Angus MYCHEL-S chloramphenicol sodium succinate INJECTABLE;INJECTION 060132-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Merck
Dow
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.